Clinical Trial Update: A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the safety and immunogenicity of BCG and the AERAS-404 TB vaccine in HIV-negative, TB-negative, BCG-naive adults. The study has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS 404
• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED